Mapping epitopes on the insulin molecule using monoclonal antibodies

Area of Science:

• Immunology
• Protein Chemistry
• Biochemistry

Background:

• Monoclonal antibodies (mAbs) are crucial tools for mapping antigenic determinants.
• Insulin's antigenic structure is complex and important for understanding immune responses and developing diagnostics or therapeutics.

Purpose of the Study:

• To map antigenic determinants on the insulin molecule using a panel of 18 monoclonal antibodies (mAbs).
• To characterize the binding affinities and epitope specificities of these mAbs.
• To estimate the diversity of antibody responses to insulin.

Main Methods:

• Preparation and characterization of 18 monoclonal antibodies (mAbs) against insulin.
• Affinity determination for mAb-insulin binding.
• Epitope mapping using analysis of mAb binding to insulin and its components.
• 18x18 matrix analysis to assess simultaneous binding of mAb pairs.

Main Results:

• Three mAbs recognized the A chain-loop determinant (A8-10), an evolutionarily diverse region.
• One mAb (10) was hypothesized to recognize a discontinuous epitope involving A4, A8, and B29 residues.
• Four mAbs bound to synthetic B chain, with other mAbs grouped by binding to different insulin species or proinsulin.
• Each of the 18 mAbs recognized a unique antigenic site on insulin, despite some targeting similar regions.
• A lower estimate of 115 possible antibodies to insulin was calculated.

Conclusions:

• Monoclonal antibodies provide a high-resolution map of insulin's antigenic determinants.
• The insulin molecule presents a diverse array of unique antigenic sites, each recognized by specific antibodies.
• The estimated number of possible antibodies to insulin suggests a complex immune recognition landscape.